Alivus Life Sciences Limited (ALIVUS)

Overview

Alivus Life Sciences Limited is a prominent pharmaceutical company dedicated to the development, manufacturing, and marketing of high-value, non-commoditized active pharmaceutical ingredients (APIs) targeting chronic therapeutic areas. The company boasts a diverse portfolio of around 151 API molecules that cater to vital therapy segments, including cardiovascular diseases, central nervous system disorders, diabetes, oncology, pain management, and anti-infectives. As a subsidiary of Nirma Limited and previously known as Glenmark Life Sciences Limited until late 2024, Alivus Life Sciences effectively combines research and development expertise with integrated support to deliver quality APIs and contract services to partners across the globe. With state-of-the-art manufacturing facilities located in India, the company holds a significant position in the global pharmaceutical supply chain, supplying markets in Europe, North America, Latin America, Japan, and beyond.

Products and Services

• Active Pharmaceutical Ingredients (APIs)

  Alivus Life Sciences specializes in developing a wide range of APIs that are essential in treating various chronic conditions. With around 151 distinct molecules, the company ensures high-quality ingredients that support effective patient care across cardiovascular diseases, diabetes, oncology, CNS disorders, and pain management.

• Contract Development and Manufacturing Services (CDMO)

  The company offers comprehensive contract development and manufacturing services to multinational and specialty pharmaceutical companies. This support enhances their drug development processes, ensuring timely delivery while maintaining the highest quality standards in compliance with regulatory requirements.

• Research and Development

  Alivus Life Sciences invests in extensive research and development initiatives to innovate and refine its API products. This commitment to R&D ensures that the company stays ahead in a rapidly evolving pharmaceutical landscape, developing therapies that are both effective and safe.

• Global Distribution

  The company's robust global footprint enables it to efficiently distribute its products to key markets across Europe, North America, Latin America, and Japan, ensuring that effective APIs are accessible to various pharmaceutical industries and healthcare providers worldwide.

• Quality Assurance and Regulatory Compliance

  Alivus Life Sciences emphasizes maintaining rigorous quality assurance protocols and complying with international regulatory standards. The company's robust quality control measures ensure that all products meet the stringent requirements necessary for a successful pharmaceutical supply chain.